GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » Float Percentage Of Total Shares Outstanding

Marinomed Biotech AG (STU:93Z) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 14, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Marinomed Biotech AG Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Marinomed Biotech AG's float shares is 0.00 Mil. Marinomed Biotech AG's total shares outstanding is 1.54 Mil. Marinomed Biotech AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Marinomed Biotech AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Marinomed Biotech AG's Institutional Ownership is 1.62%.

Marinomed Biotech AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Marinomed Biotech AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1.54
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marinomed Biotech AG (STU:93Z) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XKRX:088910 XKRX:208140 XKRX:005860 XKRX:009780 XKRX:005990 XKRX:006090 XKRX:025880 XKRX:066360 XKRX:003310 XKRX:005670 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
MARI:Austria
Address
Hovengasse 25, Korneuburg, AUT, 2100
Website
https://www.marinomed.com
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.

Marinomed Biotech AG (STU:93Z) Headlines

No Headlines